The choice of antibacterial drugs.
D000328:Adult; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002439:Cefotaxime / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D017714:Community-Acquired Infections / Q000188:drug therapy; D003428:Cross Infection / Q000188:drug therapy; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D016983:Enterococcus / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D018942:Macrolides; D016920:Meningitis, Bacterial / Q000188:drug therapy; D009503:Neutropenia / Q000188:drug therapy; D010403:Penicillin Resistance; D010406:Penicillins / Q000276:immunology; D018410:Pneumonia, Bacterial / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D018942:Macrolides; D010406:Penicillins; D002443:Ceftriaxone; D002439:Cefotaxime